๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Influence of conditioning on the outcome of allogeneic bone marrow transplantation

โœ Scribed by E. Gluckman


Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
449 KB
Volume
19
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Outcome of Chinese patients with chronic
โœ Lee, C.K.; Lie, A.K.W.; Liang, R.; Au, W.Y.; Chen, F.E.; Chim, C.S.; Kwong, Y.L. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 43 KB ๐Ÿ‘ 2 views

Clinical studies have shown that patients with chronic myeloid leukaemia (CML) treated with allogeneic bone-marrow transplantation (BMT) experience not only prolonged disease-free survival but also complete cure in some. Therefore, we followed a cohort of 81 Chinese patients who received allogeneic

Extra-medullary relapse of leukemia foll
โœ W. Y. Au; Y. L. Kwong; A. K. W. Lie; S. K. Ma; R. Liang ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 208 KB ๐Ÿ‘ 2 views

The curative effect of allogeneic bone marrow transplantation (BMT) for acute and chronic leukemia is attributed to the intensive conditioning chemotherapy with or without radiotherapy, as well as an immune-mediated graft versus leukemia (GVL) effect. A different pattern of relapse has been observed

Immunomodulatory effects of donor lympho
โœ Robert J. Soiffer; Edwin P. Alyea; Jerome Ritz ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 546 KB

Recently, donor lymphocyte infusions have been successfully used to treat patients with CML who have relapsed following allogeneic bone marrow transplantation (BMT). Responses can be achieved in more than 6&70% of patients with stable phase CML without the need for the additional high dose cytotoxic

Incidence and prognosis of cytomegalovir
โœ Dr. D. Guyotat; R. Gibert; J. Chomel; E. Archimbaud; S. Bossard; J. Maupas; D. F ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 407 KB

The incidence and the outcome of cytomegalovirus (CMV) infections were evaluated in 83 adult recipients of allogenic bone marrow transplantation. Virological and serological surveillance was performed weekly for 3 months posttransplant, and then every other week or every month until 1 year. CMV infe